[i] Abbas, T., & Dutta, A. (2009). p21 in cancer: Intricate networks and multiple activities. Nature Reviews Cancer, 9(6), 400-414. https://doi.org/10.1038/nrc2657
[ii] Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K., & Elledge, S. J. (1993). The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75(4), 805-816. https://doi.org/10.1016/0092-8674(93)90499-G
[iii] Coqueret, O. (2003). New roles for p21 and p27 cell-cycle inhibitors: A function for each cell compartment? Trends in Cell Biology, 13(2), 65-70. https://doi.org/10.1016/S0962-8924(02)00005-1
[iv] Roux, S., Lefrancais, E., Capoulade, C., Leclercq, M., & Hamel, D. (2020). Role of p21 in neuroprotection and CNS regeneration: Insights from in vitro and in vivo studies. Neuroscience Letters, 720, 134759. https://doi.org/10.1016/j.neulet.2020.134759
[v] Hsieh, J. (2012). Orchestrating transcriptional regulation of adult neurogenesis. Genes & Development, 26(10), 1010-1021. https://doi.org/10.1101/gad.186411.111
Leave a Reply